Aileen Wang
Direttore Finanziario/CFO presso CLOVER BIOPHARMACEUTICALS, LTD.
Posizioni attive di Aileen Wang
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Direttore Finanziario/CFO | 01/07/2022 | - |
| Corporate Officer/Principal | 01/03/2021 | - |
Storia della carriera di Aileen Wang
Precedenti posizioni note di Aileen Wang
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| AVEXIS INC | Corporate Officer/Principal | - | - |
Formazione di Aileen Wang
| The Pennsylvania State University | Masters Business Admin |
| Shanghai Jiao Tong University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Cina | 3 |
| Stati Uniti | 3 |
Posizioni
| Corporate Officer/Principal | 2 |
| Director of Finance/CFO | 1 |
| Masters Business Admin | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Health Technology |
| Aziende private | 1 |
|---|---|
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
- Borsa valori
- Insiders
- Aileen Wang
- Esperienza
